Relevance of HPV mRNA detection in a population of ASCUS plus women using the NucliSENS EasyQ® HPV assay

Journal of Clinical Virology

Volumn 47, Issue 2, 2010, Pages 177-181

  Halfon, Philippe ^a,b   Benmoura, Dominique ^b   Agostini, Aubert ^c   Khiri, Hacene ^a   Martineau, Agnés ^a   Penaranda, Guillaume ^d   Blanc, Bernard ^b  

^a Laboratoire Alphabio   (France)

^b Hospital Ambroise Pare   (France)

^c HÔPITAL DE LA CONCEPTION   (France)

^d CDL Pharma   (France)

Author keywords

Genotypes; HPV; Hybrid capture 2; Linear array; NucliSENS EasyQ HPV

Indexed keywords

VIRUS RNA;

ADULT; AGED; ARTICLE; ASSAY; CANCER GRADING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; FEMALE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN TISSUE; HYBRID CAPTURE 2 ASSAY; INTERMETHOD COMPARISON; LINEAR ARRAY TEST; MAJOR CLINICAL STUDY; NONHUMAN; NUCLISENS EASYQ; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SQUAMOUS EPITHELIUM; UTERINE CERVIX CANCER; UTERINE CERVIX DYSPLASIA; UTERUS BIOPSY; VIRUS DETECTION; WART VIRUS;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RNA, MESSENGER; RNA, VIRAL; SELF-SUSTAINED SEQUENCE REPLICATION; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 74149093529     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2009.11.011     Document Type: Article

References (22)

1. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 (1999) 12-19
2. Clifford G., Franceschi S., Diaz M., Munoz N., and Villa L.L. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 24 Suppl. 3 (2006) S3/26-34
3. Bulkmans N.W., Berkhof J., Rozendaal L., van Kemenade F.J., Boeke A.J., Bulk S., et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 370 (2007) 1764-1772
4. Bulkmans N.W., Rozendaal L., Snijders P.J., Voorhorst F.J., Boeke A.J., Zandwijken G.R., et al. POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women. Int J Cancer 110 (2004) 94-101
5. Moscicki A.B., Schiffman M., Kjaer S., and Villa L.L. Chapter 5: updating the natural history of HPV and anogenital cancer. Vaccine 24 Suppl. 3 (2006) S3/42-51
6. Castle P.E., Dockter J., Giachetti C., Garcia F.A., McCormick M.K., Mitchell A.L., et al. A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical precancer and cancer. Clin Cancer Res 13 (2007) 2599-2605
7. Cuzick J., Clavel C., Petry K.U., Meijer C.J., Hoyer H., Ratnam S., et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 119 (2006) 1095-1101
8. Cuzick J., Szarewski A., Cubie H., Hulman G., Kitchener H., Luesley D., et al. Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 362 (2003) 1871-1876
9. Trope A., Sjoborg K., Eskild A., Cuschieri K., Eriksen T., Thoresen S., et al. Performance of human papillomavirus DNA and mRNA testing strategies for women with and without cervical neoplasia. J Clin Microbiol 47 (2009) 2458-2464
10. Lie A.K., and Kristensen G. Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma. Expert Rev Mol Diagn 8 (2008) 405-415
11. Lie A.K., Risberg B., Borge B., Sandstad B., Delabie J., Rimala R., et al. DNA- versus RNA-based methods for human papillomavirus detection in cervical neoplasia. Gynecol Oncol 97 (2005) 908-915
12. McCredie M.R., Sharples K.J., Paul C., Baranyai J., Medley G., Jones R.W., et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 9 (2008) 425-434
13. Molden T., Kraus I., Karlsen F., Skomedal H., Nygard J.F., and Hagmar B. Comparison of human papillomavirus messenger RNA and DNA detection: a cross-sectional study of 4,136 women >30 years of age with a 2-year follow-up of high-grade squamous intraepithelial lesion. Cancer Epidemiol Biomarkers Prev 14 (2005) 367-372
14. Molden T., Nygard J.F., Kraus I., Karlsen F., Nygard M., Skare G.B., et al. Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: a 2-year follow-up of women with ASCUS or LSIL Pap smear. Int J Cancer 114 (2005) 973-976
15. Monsonego J., Pollini G., Evrard M.J., Sednaoui P., Monfort L., Zerat L., et al. Detection of human papillomavirus genotypes among high-risk women: a comparison of hybrid capture and linear array tests. Sex Transm Dis 35 (2008) 521-527
16. Smith J.S., Lindsay L., Hoots B., Keys J., Franceschi S., Winer R., et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121 (2007) 621-632
17. Szarewski A., Ambroisine L., Cadman L., Austin J., Ho L., Terry G., et al. Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears. Cancer Epidemiol Biomarkers Prev 17 (2008) 3033-3042
18. Woodman C.B., Collins S.I., and Young L.S. The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 7 (2007) 11-22
19. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2 (2002) 342-350
20. Munoz N., Castellsague X., de Gonzalez A.B., and Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 24 Suppl. 3 (2006) S3/1-10
21. Pretet J.L., Jacquard A.C., Carcopino X., Charlot J.F., Bouhour D., Kantelip B., et al. Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study. Int J Cancer 122 (2008) 428-432
22. Pretet J.L., Jacquard A.C., Saunier M., Clavel C., Dachez R., Gondry J., et al. Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesions in France and comparison with CIN2/3 and invasive cervical cancer: the EDiTH III study. Gynecol Oncol 110 (2008) 179-184